Dataset de Zenodo · Madè, Alisia
LEF1-AS1 Deregulation in the Peripheral Blood of Patients with Persistent Post-COVID Symptoms
- Licencia
- CC BY 4.0uso comercial permitidoTexto de la licencia
- Esta licencia permite el uso comercial. Normalmente hay que citar al autor; consulta la licencia para ver las condiciones exactas.
- Actualizado
- 16 feb 2026
Descripción
Abstract: Long COVID denotes the persistence of symptoms after acute SARS-CoV-2 infection lasting for at least two months without another identifiable cause. Affecting an estimated 15% of COVID-19 patients, long COVID manifests in a wide range of symptoms. Despite extensive research on its one-year effects, limited data exist beyond 12 months. Due to the different manifestations of long COVID, its diagnosis can be challenging. Identifying potential mechanistic contributors and biomarkers would be highly valuable. Recent studies have highlighted the potential of noncoding RNAs (ncRNAs) as biomarkers for disease stratification in COVID-19. Specifically, we have recently identified miR-144-3p and a subset of lncRNAs as candidates for assessing disease severity and outcomes in COVID-19. This nested case–control study extends such investigations to 98 long COVID patients recruited 18 months after hospitalization, exploring the relationship between circulating ncRNA expression and persistent symptoms. While miR-144-3p, HCG18, and lncCEACAM21 expression did not differ between symptomatic and asymptomatic patients, LEF1-AS1 was downregulated in the peripheral blood mononuclear cells…
Descripción de Zenodo, abreviada.